1. Development and immunogenic potentials of chitosan-saponin encapsulated DNA vaccine against avian infectious bronchitis coronavirus
- Author
-
Faruku Bande, Yeap Swee Keong, Siti Suri Arshad, Tan Sheau Wei, Saeid Khadkodaei, Hassan Moeini, Abdul Rahman Omar, Yusuf Abba, Ibrahim Abubakar Anka, and Mohd Hair Bejo
- Subjects
0301 basic medicine ,Cross Protection ,030106 microbiology ,Infectious bronchitis virus ,Saponin ,Immunization, Secondary ,CD8-Positive T-Lymphocytes ,medicine.disease_cause ,Antibodies, Viral ,Plasmid ,Microbiology ,Article ,Poultry ,DNA vaccination ,03 medical and health sciences ,Immunogenicity, Vaccine ,Nanoparticle ,medicine ,Vaccines, DNA ,Animals ,Bronchitis ,Poultry Diseases ,Coronavirus ,Chitosan ,Immunity, Cellular ,biology ,Viral Vaccine ,Immunogenicity ,Vaccination ,Viral Vaccines ,Saponins ,Avian infectious bronchitis ,biology.organism_classification ,Virology ,030104 developmental biology ,Infectious Diseases ,Nanoparticles ,Avian infectious bronchitis virus ,Coronavirus Infections ,Bivalent DNA vaccine ,Chickens - Abstract
Infectious bronchitis (IB) is an economically important disease of poultry that also serve as model for the understanding of other coronaviruses associated diseases. IB is considered as a major challenge to the poultry industry worldwide as a result of its effect on egg production, weight gain as well as mortality. Different IBV genotypes continue to emerge, thus, the need for broad based vaccines to curb the disease. Based on bioinformatic data obtained in this study, sets of monovalent (either M41 or CR88) and bivalent DNA vaccines encoding the S1 glycoprotein from two different strains namely, M41 and CR88 were developed. The candidate vaccine was further encapsulated with a chitosan-saponin nanoparticle with the view to enhance its immunogenicity. Following in vitro characterization of the constructs, the vaccine candidates were tested in specific pathogen free (SPF) chickens. Analysis of humoral responses revealed a significant increase in anti-IBV antibody after immunization with the bivalent DNA plasmid (pBudCR88-S1/M41-S1). Likewise, cell mediated immune (CMI) response was significantly higher in vaccinated groups as compared to the unvaccinated chickens. Vaccinated chickens exhibited milder clinical signs as well as tracheal and kidney lesion scores following virus challenge as compared to the control groups. Additionally, encapsulation of the bivalent DNA vaccine with chitosan-saponin nanoparticles was found to improve protection against challenge with IBV strains M41 and CR88 as revealed by a significant reduction (p, Highlights • DNA vaccine could offer promising advantage against infectious bronchitis in poultry. • Vaccination with IBV S-1 gene based DNA vaccine leads to improved antibody and T cell responses. • Encapsulation of the vaccine with chitosan and Saponin enhances the immune response and abrogated the need for multiple booster administration. • The vaccine offered protection to vaccinated chickens as revealed by reduction in oropharyngeal and cloacal virus shedding as well as reduced tracheal and kidney lesion score following challenge.
- Published
- 2020
- Full Text
- View/download PDF